Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhangxuan Chen
Institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing Medical University,
Nanjing University
Observed institutions:
Northwestern Polytechnical University,
Nanjing General Hospital of Nanjing Military Command,
State Key Laboratory of Solidification Processing,
Nanjing Medical University,
Nanjing University
ORCID:
0009-0009-7732-5325
Observed ORCID:
0009-0009-7732-5325
OpenAlex ID:
A5024216080
Low-Temperature Solution Growth and Characterization of Halogen (Cl, I)-Doped CsPbBr3 Crystals
2020
·
Fangbao Wang
, Hongjian Zhang
, et al.
·
Crystal Growth & Design
·
47
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors
2024
·
Yunchang Meng
, Yimin Wang
, et al.
·
Translational Lung Cancer Research
·
12
Efficacy and safety of perioperative, neoadjuvant, or adjuvant immunotherapy alone or in combination with chemotherapy in early-stage non-small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials
2024
·
Yunchang Meng
, Qingfeng Zhang
, et al.
·
Therapeutic Advances in Medical Oncology
·
12
Lymph nodes metastatic burden as a prognosticator for advanced non-small cell lung cancer: a real-world study
2025
·
Zhangxuan Chen
, Qingfeng Zhang
, et al.
·
Journal of Thoracic Disease
·
2
An exploratory ImmunoScore based on early on-treatment changes in NLR and LDH in small-cell lung cancer receiving first-line chemoimmunotherapy
2026
·
Yang Yao
, Xinjing Li
, et al.
·
Future Oncology
·
1
Efficacy and Safety of Neoadjuvant, Adjuvant, and Perioperative Immune Checkpoint Inhibitors Single Agent or with Chemotherapy in Resectable NSCLC: Indirect Comparison and Clinicopathological Impact
2024
·
Yunchang Meng
, Qingfeng Zhang
, et al.
·
1
PDF
Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non‑small cell lung cancer
2026
·
Zhangxuan Chen
, Jingsi Chen
, et al.
·
Oncology Letters
PDF
Efficacy and safety of third-generation EGFR-TKI rechallenge therapy in advanced non-small cell lung cancer patients with EGFR mutation: a retrospective cohort study
2026
·
Jiajie Sun
, Xinjing Li
, et al.
·
Translational Lung Cancer Research
Comparison Between EGFR-TKI Efficacy in Early-Stage Non-small Cell Lung Cancer and Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
2026
·
Bingxue Wang
, Yang Yao
, et al.
·
Lung
Comparative efficacy and safety of first-line combination therapies with third-generation EGFR-TKIs in advanced EGFR -mutant NSCLC: A systematic review and network meta-analysis.
2026
·
Hongbing Liu
, Zhangxuan Chen
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
10
Citation count:
75
H-index:
3
I10-index:
3
Year
Topic
Type